Fecundis — Seed · €722K

Equity crowdfunding round on Capital Cell that ran from 10 January to 9 February 2024. It raised €721,539 from 197 investors against a €600K target, for 10% of the company at a €5.5M pre-money valuation, to fund HyperSperm clinical trials. It is not clear from the sources whether this money was later counted inside the October 2024 seed total.